BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24876746)

  • 1. Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma.
    Liu WC; Liu QY
    World J Gastroenterol; 2014 May; 20(20):6252-61. PubMed ID: 24876746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenesis of hepatitis B virus-related hepatocellular carcinoma].
    Zhang Y; Guo J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):152-6. PubMed ID: 26983488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus X gene and hepatocarcinogenesis.
    Ng SA; Lee C
    J Gastroenterol; 2011 Aug; 46(8):974-90. PubMed ID: 21647825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of sex hormones and receptors in HBV infection and development of HBV-related HCC.
    Nuermaimaiti A; Chang L; Yan Y; Sun H; Xiao Y; Song S; Feng K; Lu Z; Ji H; Wang L
    J Med Virol; 2023 Dec; 95(12):e29298. PubMed ID: 38087447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.
    Chaturvedi VK; Singh A; Dubey SK; Hetta HF; John J; Singh MP
    Microb Pathog; 2019 Mar; 128():184-194. PubMed ID: 30611768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma.
    Tu T; Budzinska MA; Shackel NA; Jilbert AR
    Liver Int; 2015 Jul; 35(7):1786-800. PubMed ID: 25640596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification for hepatitis B virus related hepatocellular carcinoma.
    Lin CL; Kao JH
    J Gastroenterol Hepatol; 2013 Jan; 28(1):10-7. PubMed ID: 23094699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender disparity in chronic hepatitis B: Mechanisms of sex hormones.
    Wang SH; Chen PJ; Yeh SH
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1237-45. PubMed ID: 25708186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanisms of hepatitis B virus-associated hepatocellular carcinoma].
    Park NH; Chung YH
    Korean J Hepatol; 2007 Sep; 13(3):320-40. PubMed ID: 17898549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
    Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms.
    Bréchot C
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S56-61. PubMed ID: 15508104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B virus and hepatocellular carcinoma.
    Pollicino T; Saitta C
    World J Gastroenterol; 2014 May; 20(20):5951-61. PubMed ID: 24876718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation.
    Song X; Tan S; Wu Z; Xu L; Wang Z; Xu Y; Wang T; Gao C; Gong Y; Liang X; Gao L; Spear BT; Ma C
    Int J Cancer; 2018 Dec; 143(12):3120-3130. PubMed ID: 29752719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
    Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
    Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from southern China.
    Zhu P; Tan D; Peng Z; Liu F; Song L
    Acta Biochim Biophys Sin (Shanghai); 2007 Apr; 39(4):265-72. PubMed ID: 17417681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.
    Sartorius K; An P; Winkler C; Chuturgoon A; Li X; Makarova J; Kramvis A
    Front Immunol; 2021; 12():661204. PubMed ID: 33995383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis B virus infection in Asian countries.
    Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
    Lamontagne J; Steel LF; Bouchard MJ
    World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms.
    Zheng B; Zhu YJ; Wang HY; Chen L
    Sci China Life Sci; 2017 Jun; 60(6):575-584. PubMed ID: 28547581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus and hepatocellular carcinoma.
    Arbuthnot P; Kew M
    Int J Exp Pathol; 2001 Apr; 82(2):77-100. PubMed ID: 11454100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.